Journal: Current Pharmaceutical Design Volume: 22 Issue: 8 Year: 2016 Page: 1013-1021 Author(s): Zsuzsanna Bohár,Ãrpád Párdutz,László Vécsei
Journal: Current Pharmaceutical Design Volume: 22 Issue: 8 Year: 2016 Page: 1074-1085 Author(s): Michael Maes,George Anderson
Journal: CNS & Neurological Disorders - Drug Targets Volume: 17 Issue: 8 Year: 2018 Page: 634-647 Author(s): Heidi Ormstad,Vesna Bryn,Robert Verkerk,Ola H. Skjeldal,Bente Halvorsen,Ola Didrik Saugstad,Jorn Isaksen,Michael Maes
Journal: Current Pharmaceutical Design Volume: 22 Issue: 8 Year: 2016 Page: 1049-1059 Author(s): Jens O. Watzlawik,Bharath Wootla,Moses Rodriguez
Ebook: Frontiers in Drug Discovery Volume: 2 Year: 2017 Author(s): George Anderson,Michael Maes Doi: 10.2174/9781681084732117020012
Journal: Current Neuropharmacology Volume: 12 Issue: 2 Year: 2014 Page: 148-167 Author(s): George Anderson,Michael Maes
Journal: Current Pharmaceutical Design Volume: 22 Issue: 8 Year: 2016 Page: 949-954 Author(s): Liliana DellâOsso,Claudia Carmassi,Federico Mucci,Donatella Marazziti
Journal: Current Pharmaceutical Design Volume: 22 Issue: 8 Year: 2016 Page: 963-977 Author(s): Gerwyn Morris,André F. Carvalho,George Anderson,Piotr Galecki,Michael Maes
Journal: Current Pharmaceutical Design Volume: 22 Issue: 40 Year: 2016 Page: 6142-6151 Author(s): George Anderson,Moonsang Seo,Michael Berk,Andre F. Carvalho,Michael Maes
Journal: CNS & Neurological Disorders - Drug Targets Volume: 16 Issue: 4 Year: 2017 Page: 472-483 Author(s): Chutima Roomruangwong,Buranee Kanchanatawan,Sunee Sirivichayakul,George Anderson,Andre F. Carvalho,Sebastien Duleu,Michel Geffard,Michael Maes
Previous Next